Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vaccine offers hope in fight against major chicken disease
The recombinant vaccines have potential to be more cost-effective and respond to emerging new virus strains.
Researchers test effectiveness of recombinant virus vaccine

Researchers have developed a new vaccine strategy that could help chickens in the fight against infectious bronchitis.

Current vaccines that protect against infectious bronchitis guard against some strains of the virus, but not others. Scientists believe these failures are associated with differences in the spike protein - the protein which enables the virus to attach to and enter cells - between strains of the virus.

Writing in the Journal Of Virology, researchers describe how they tested a new approach using a specialist type of vaccine, known as recombinant virus vaccine. These vaccines use harmless or weak versions of a virus or bacteria to introduce microbes into cells into the body.

The team used recombinant viruses with different spike proteins as vaccines to build two versions of a harmless virus. They found that the vaccine offered partial protection against infectious bronchitis virus, but further research is needed to develop a more robust vaccine.

Researchers say the recombinant vaccines have potential to be more cost-effective and respond to emerging new virus strains. The next step will be to develop a vaccine that remains harmless but induces a stronger immune response.

Professor Lonneke Vervelde, who led the study at the University’s Roslin Institute, said: “There is a real need to develop new vaccines against infectious bronchitis that protect against multiple strains and offer rapid responses. We are trying to make a vaccine that offers broad protection, but further research is needed to develop a more robust vaccine.”

Dr Erica Bickerton at the Pirbright Institute, who also took part in the study, said: “Our research hopes to develop more cost-effective and efficient commercial vaccines that are capable of protecting chickens against this serious disease.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.